Virax Biolabs Group Ltd 20-F for FY2025
Virax Biolabs Group Ltd (VRAX)
20-F
2025-07-02
For: 2025-03-31
View Original
Added on
April 08, 2026
About this 20-F
Virax Biolabs Group Ltd filed this 20-F on July 2, 2025, covering the fiscal year ended March 31, 2025 (FY2025).
Headline figures
Fiscal year ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6331
- down 96.0% from $156.42K a year earlier
- Net loss
- $6.06M
- compared with a net loss of $6.73M a year earlier
- Diluted EPS
- -$1.62
- compared with -$3.36 a year earlier